Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51201-51250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05128825
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2Recruiting
170 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor70 locations
NCT05469373
ESIS in Pediatric DRE
N/ARecruiting
86 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT05492175
Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation
NARecruiting
72 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05992610
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NARecruiting
40 participants
Started: Feb 17, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT04772963
Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)
N/ARecruiting
300 participants
Started: Feb 17, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT04404400
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
PHASE3Recruiting
1,092 participants
Started: Feb 17, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05290038
ARON-2 Study-Multicentric International Retrospective Study
N/ARecruiting
367 participants
Started: Feb 17, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05069922
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation
NARecruiting
100 participants
Started: Feb 17, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT04732091
Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease
N/ARecruiting
540 participants
Started: Feb 17, 2022 · Completed: Feb 1, 2026
2 conditions2 sponsors2 locations
NCT04914611
Real World Assessment of People Living With Chronic Hepatitis B in Australia
N/ARecruiting
10,000 participants
Started: Feb 17, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor19 locations
NCT05527626
Chronic Kidney Disease - REAL Life Study in Alsace
N/ARecruiting
3,000 participants
Started: Feb 17, 2022 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT05075980
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
PHASE2Recruiting
174 participants
Started: Feb 16, 2022 · Completed: Nov 15, 2035
12 conditions1 sponsor9 locations
NCT05489757
Quantitative Fluorescence Angiography With ICG for Perfusion Assessment During Surgery
NARecruiting
239 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05388487
Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors
PHASE1Recruiting
54 participants
Started: Feb 16, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT05641610
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
PHASE1/PHASE2Recruiting
21 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05977088
Prediction of Effectiveness of rTMS Application in Alzheimer's Patients
NARecruiting
40 participants
Started: Feb 16, 2022 · Completed: Dec 30, 2025
1 condition3 sponsors1 location
NCT05137119
Staphylococcus Aureus Network Adaptive Platform Trial
PHASE4Recruiting
8,000 participants
Started: Feb 16, 2022 · Completed: Dec 1, 2028
1 condition17 sponsors151 locations
NCT05122559
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
PHASE2Recruiting
98 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors1 location
NCT05004727
Multi-Center PAMPA Study
PHASE4Recruiting
176 participants
Started: Feb 16, 2022 · Completed: Jul 31, 2028
1 condition2 sponsors5 locations
NCT04707300
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)
PHASE1/PHASE2Recruiting
10 participants
Started: Feb 16, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor5 locations
NCT05695456
Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
PHASE1/PHASE2Recruiting
25 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04998188
Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis
NARecruiting
204 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04448184
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
PHASE3Recruiting
662 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors11 locations
NCT05421273
Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: a Multicenter Randomized Trial (BURST-RAP Study)
NARecruiting
96 participants
Started: Feb 16, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor6 locations
NCT05239533
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
PHASE2Recruiting
41 participants
Started: Feb 16, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor7 locations
NCT05283850
Surviving PEA in Roanoke (SPEAR) Study
PHASE2/PHASE3Recruiting
342 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT04888481
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
PHASE2Recruiting
600 participants
Started: Feb 15, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05232942
Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
N/ARecruiting
200 participants
Started: Feb 15, 2022 · Completed: Aug 15, 2024
2 conditions1 sponsor1 location
NCT05119296
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
PHASE2Recruiting
20 participants
Started: Feb 15, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05210907
Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia
PHASE1Recruiting
5 participants
Started: Feb 15, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05241340
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
PHASE2Recruiting
33 participants
Started: Feb 15, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05263206
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
PHASE3Recruiting
284 participants
Started: Feb 15, 2022 · Completed: Aug 25, 2027
1 condition1 sponsor80 locations
NCT05216861
Evaluation of a Collaborative Intervention to Promote Employer Contact and RTW Among People With CMD or Chronic Pain
NARecruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 21, 2025
2 conditions2 sponsors1 location
NCT05214937
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
NARecruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05228262
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
NARecruiting
150 participants
Started: Feb 15, 2022 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT05255536
Effect of Different Local Anesthetic Volumes of Serratus Anterior Plan Block After Video-Assisted Thoracoscopic Surgery
NARecruiting
60 participants
Started: Feb 15, 2022 · Completed: May 15, 2024
4 conditions1 sponsor1 location
NCT05756036
Torque Teno Virus: A Biomarker of Immunosuppression
N/ARecruiting
400 participants
Started: Feb 15, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05255393
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
N/ARecruiting
1,026 participants
Started: Feb 15, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05493813
Total Intravenous Anesthesia Versus Sevoflurane Anesthesia for Endovascular Thrombectomy in Acute Ischemic Stroke
NARecruiting
298 participants
Started: Feb 15, 2022 · Completed: Dec 30, 2025
6 conditions1 sponsor1 location
NCT04902508
Evaluation of an Explicit Approach
NARecruiting
200 participants
Started: Feb 15, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT05238519
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
PHASE3Recruiting
300 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors2 locations
NCT05138133
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
PHASE3Recruiting
360 participants
Started: Feb 15, 2022 · Completed: Jul 7, 2028
1 condition1 sponsor233 locations
NCT05197738
Research Framework Exploring Sleep Health
N/ARecruiting
100,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2041
4 conditions1 sponsor1 location
NCT05328960
The Pandemic's Effect on Diagnosis and Treatment of Rectal Cancer
N/ARecruiting
8,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07205003
Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders
N/ARecruiting
140 participants
Started: Feb 15, 2022 · Completed: Sep 18, 2026
2 conditions1 sponsor1 location
NCT05408507
Care Planning Framework in Advanced Cancer (ABC123)
NARecruiting
70 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05300685
Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty
PHASE3Recruiting
60 participants
Started: Feb 15, 2022 · Completed: Mar 1, 2026
1 condition2 sponsors2 locations
NCT06115122
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
N/ARecruiting
3,000 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2041
7 conditions7 sponsors1 location
NCT04307992
AneuFix - Prophylactic Sac Filling
NARecruiting
5 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05214391
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
PHASE2Recruiting
30 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location